Genomma Lab Internacional SAB de CV

OTC:GNMLF

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GNMLF's stock price target?

Price Target

1.5929 USD

According to Wall Street analysts, the average 1-year price target for GNMLF is 1.5929 USD with a low forecast of 0.9995 USD and a high forecast of 1.8833 USD.

What is the Revenue forecast for Genomma Lab Internacional SAB de CV?

Projected CAGR

6%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.

What is the Gross Profit forecast for Genomma Lab Internacional SAB de CV?

Projected CAGR

7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 7%.

What is the Operating Income forecast for Genomma Lab Internacional SAB de CV?

Projected CAGR

7%

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 7%.

What is the Pre-Tax Income forecast for Genomma Lab Internacional SAB de CV?

Projected CAGR

14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Genomma Lab Internacional SAB de CV?

Projected CAGR

15%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 5 years is 15%.